Bellicum Pharmaceuticals
Bellicum Pharmaceuticals is a biotechnology company focused on discovering and developing innovative cellular immunotherapies for cancers and other serious diseases. Leveraging proprietary technologies, Bellicum aims to improve the safety, efficacy, and control of cell therapies, including CAR-T and TCR-T products. The company’s pipeline features clinical and preclinical programs designed to address unmet medical needs in hematologic malignancies and solid tumors. Bellicum’s approach centers on modular cell therapy platforms that enable precise modulation of immune cells, enhancing therapeutic outcomes. With a commitment to advancing next-generation cell therapies, Bellicum Pharmaceuticals collaborates with leading research institutions and industry partners to accelerate the development of transformative treatments for patients worldwide.
